Scenesse (afamelanotide) increases the time people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), two types of porphyria,…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
A new artificial intelligence (AI) algorithm may help reduce the time it takes to diagnose…
Oral iron supplements may help people with erythropoietic protoporphyria (EPP) build back their iron reserves and increase the levels…
Certain triggers of acute intermittent porphyria (AIP) may also affect the function of the brain’s mitochondria — the bean-shaped…
Acute intermittent porphyria (AIP) manifests in a variety of ways, but in China, the most common symptoms are abdominal…
Treatment with cimetidine, an over-the-counter (OTC) medication normally used to treat heartburn, may help children with erythropoietic protoporphyria (EPP)…
A rarely reported mutation in the HMBS gene was identified as the cause of recurrent, hard-to-treat episodes of acute…
Different mutations in the HMBS gene — the cause of acute intermittent porphyria (AIP) — are not associated with…
A new mutation in the HMBS gene was identified as the cause of acute intermittent porphyria (AIP) in a…
People with acute intermittent porphyria (AIP) who have high levels of porphyrin precursors in the urine are more likely…